Label-Free Metabolic Classification of Single Cells in Droplets Using the Phasor Approach to Fluorescence Lifetime Imaging Microscopy. by Ma, Ning et al.
UC Irvine
UC Irvine Previously Published Works
Title
Label-Free Metabolic Classification of Single Cells in Droplets Using the Phasor Approach to 
Fluorescence Lifetime Imaging Microscopy.
Permalink
https://escholarship.org/uc/item/5h87w903
Journal
Cytometry. Part A : the journal of the International Society for Analytical Cytology, 95(1)
ISSN
1552-4922
Authors
Ma, Ning
Kamalakshakurup, Gopakumar
Aghaamoo, Mohammad
et al.
Publication Date
2019
DOI
10.1002/cyto.a.23673
License
https://creativecommons.org/licenses/by/4.0/ 4.0
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Label-Free Metabolic Classification of Single Cells in Droplets 
using the Phasor Approach to Fluorescence Lifetime Imaging 
Microscopy
Ning Ma1,2,4,*, Gopakumar Kamalakshakurup1,4,*, Mohammad Aghaamoo1, Abraham P. 
Lee1,3,4,§, and Michelle Digman1,2,4,§
1Biomedical Engineering Department, University of California, Irvine CA USA
2Laboratory for Fluorescence Dynamics, University of California, Irvine CA USA
3Mechanical & Aerospace Engineering Department, University of California, Irvine CA USA
4Center for Advanced Design & Manufacturing of Integrated Microfluidics (CADMIM), University of 
California, Irvine CA USA
Abstract
Characterization of single cell metabolism is imperative for understanding subcellular functional 
and biochemical changes associated with healthy tissue development and the progression of 
numerous diseases. However, single-cell analysis often requires the use of fluorescent tags and cell 
lysis followed by genomic profiling to identify the cellular heterogeneity. Identifying individual 
cells in a non-invasive and label-free manner is crucial for the detection of energy metabolism 
which will discriminate cell types and most importantly critical for maintaining cell viability for 
further analysis. Here, we have developed a robust assay using the droplet microfluidic technology 
together with the phasor approach to Fluorescence Lifetime Imaging Microscopy (FLIM) to study 
cell heterogeneity within and among the leukemia cell lines (K-562 and Jurkat). We have extended 
these techniques to characterize metabolic differences between proliferating and quiescent cells—
a critical step toward label-free single cancer cell dormancy research. The result suggests a 
droplet-based non-invasive and label-free method to distinguish individual cells based on their 
metabolic states, which could be used as an upstream phenotypic platform to correlate with 
genomic statistics.
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Introduction
Single-cell analysis is important to study heterogeneity among individual cells which can 
lead to an improvement in disease diagnosis and treatment strategies(1,2). The ability to 
confine single cells in individual droplets enabled microfluidic devices to evolve as a 
valuable tool for single cell analysis(3). In general, single-cell encapsulation in droplets is 
performed randomly by optimizing the concentration of cells in the sample solution such 
that no droplets contain more than one cell in them. In such cases, the encapsulation 
efficiency is as low as 5%, which is dictated by Poisson statistics. However, the deterministic 
single cell encapsulation involves both active and passive methods(4). Active techniques 
include both laser-induced optical trapping(5) and pico-ejection techniques(6). These 
techniques can deliver 100% single cell encapsulation efficiency; however, the throughput is 
very low (<1 Hz). Passive techniques utilize hydrodynamic concepts to perform high-
efficiency single cell encapsulation. One of the passive techniques utilizes the Raleigh-
Plateau instability jet breakup at the flow focusing junction such that the droplets with a 
single cell will be larger than the empty ones. The lateral induced drift caused by the 
unequal oil flow rates and steric interaction at the bifurcation enable droplet sorting at 79.2% 
efficiency(7). Another method utilizes inertial microfluidic principles to order the cells along 
the channel wall in a curved channel or in a long, high aspect ratio microchannel to perform 
single cell encapsulation at 80% efficiency(8,9). Recently, our group has reported a 
microvortex based technique that can perform both high-efficiency single cell encapsulation 
(~50%) and size-selective cell capture in a single microfluidic device at low cell loading 
density(10). In this study, we used Poisson-based single cell encapsulation in droplets. The 
cell concentration and the flow rates are optimized to achieve maximum encapsulation 
efficiency with no doublets or triplets.
Encapsulating single cells is merely the first step in single cell analysis. Once cells are 
captured, identification becomes difficult given that they no longer exhibit a phenotypic 
profile or significant morphological difference. Current platforms to perform single-cell 
studies includes flow cytometry(11), and automated microscopy(12). Examples of single cell 
analysis in droplets include screening single cells against the library of drug compounds(13), 
genome-wide expression profiling using Dropseq(14) and inDrop(15) methodologies. 
Notably, the single-cell analysis in droplets mostly involves cell lysis and genomic analysis 
including PCR and sequencing to identify the gene expression level. However, genotyping 
relies on end results, and fluorescent labeling or cell lysis is not desirable for continuous and 
dynamic single cell monitoring.
To meet the unmet need for single cell detection and identification, we have developed 
Fluorescence lifetime imaging microscopy (FLIM) which is a non-invasive, label-free assay 
that measures energy metabolism in encapsulated cells. Metabolism is fundamentally 
important for identification between healthy and unhealthy cells, tumor heterogeneity, 
wound healing, diabetes, and neurodegenerative disorders(16–19). The quantitative 
measurement of the metabolites can be applied as a diagnostic and drug screening tool due 
to the reflection of the changes during disease development and treatment response(20–22). 
The accurate determination of metabolites from a single cell is critical.
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The pioneering work of Britton Chance has opened the field of spectroscopy and optical 
imaging to detect metabolic intrinsic fluorescent co-factors in cells and tissues (23,24). 
These spectroscopic techniques provide information of the natural biomarkers involved in 
different stages of the electron transport chain, such as the reduced form of nicotinamide 
adenine dinucleotide (NADH), nicotinamide adenine dinucleotide phosphate(NADPH) and 
flavins (FAD)(25,26). Skala et al. have used fluorescence intensity of FAD divided by the 
fluorescence intensity of NADH to characterize the redox ratio in living cells(27). FLIM has 
also been used to determine the changes in metabolism from fluorescence lifetime of NADH 
and FAD(27–30). We also apply the phasor analysis with FLIM, in which the Fourier cosine 
and sine transforms of the experimental decay are computed and represented by polar 
coordinates “g” and “s” in the transformation function on a polar coordinate graph termed 
the ‘phasor plot’.(31,32) Phasor approach provides fit-less and graphical data analysis which 
is more intuitive(31,33–35). We apply 740nm to excite the intrinsic fluorescent species 
which can give the maximum excitation for NAD(P)H(36). Given that endogenous 
molecules such as collagen, retinoids, flavins, folate, and NAD(P)H are intrinsically 
fluorescent in live cells(37,38), fluorescence lifetime data can have a mixture of all these 
species making it difficult to identify these components. Using a short pass filter to collect 
the emission of NAD(P)H and the phasor method, contributions from these different 
biochemical species are easily identified and separated. Our previous work has showed a 
leukemia screening platform combines FLIM and microfluidic single-cell trapping which 
can successfully distinguish the white blood cells and leukemia cells(39). However, it has 
been demonstrated cell-environment may contribute to the leukemia cell metabolism, 
survival rate, proliferation rate, etc.(40,41) The novel microfluidic single encapsulated oil 
droplet can be used to isolate and maintain the cell metabolic signature. And this design can 
also help with the future personal therapeutic drug introduction and FLIM screening (13). 
Compared to the single cell fluorescence-activated cell sorting(FACS) which has been 
largely used in clinic, the presented metabolic screening platform doesn’t have to use the 
fluorescent tag with expensive antibodies which also might cause cell damage and cell 
behavior alteration.
Here we have applied the phasor-FLIM approach to leukemia cells and serum-free treated 
fibroblasts encapsulated one-to-one in droplets and have captured detailed data on their 
metabolic states. The encapsulated leukemia cells display heterogeneous phasor-FLIM 
signatures due to different proliferation rates. However, the difference between the metabolic 
lifetimes of the two leukemia cell types used, are still distinguishable. Furthermore, we 
found that serum-starved fibroblasts, under a quiescent state, deviate significantly from that 
of the fibroblasts cultured under normal condition, indicating that lifetime trajectories can be 
used to detect metabolic alterations during different stages of cell cycle. Our results show 
that under serum-free treatment, there is a higher free NADH and NADPH production due to 
increased glycolysis through the pentose phosphate pathway which may contribute to 
detoxify free radicals or to synthesize fatty acids(42–44). In summary, our non-invasive 
phasor-FLIM approach provides an intuitive, sensitive, quantitative method to assess 
metabolic response in encapsulated single cell droplets which can be applied for fast 
screening of the cancer cells and drug development.
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Results and Discussion
Single Cell Encapsulation in Droplets
The microfluidic device has an expansion flow focusing geometry as shown in Fig. 1A. This 
design has been used by our group for droplet-based applications since 2006 (45). The 
device consists of two inlets: Cells suspended in the culture media is injected through the 
left inlet while the oil phase enters the device through the other inlet. Both the inlets have 
filters (20 μm) to prevent the debris from clogging the flow-focusing junction. The 
microfluidic channel height is made comparable to the cell diameter such that no two cells 
roll over each other. Figure 1B illustrates the microfluidic device made from 
Polydimethylsiloxane (PDMS). It has a unique droplet collection chamber design to prevent 
the droplet motion throughout the data acquisition process for FLIM.
The process of encapsulation of cells one-to-one into the droplets is illustrated in Fig. 2A. 
The droplet diameter and droplet generation frequency is adjusted according to the cell 
influx to ensure that maximum encapsulation efficiency is achieved. This is achieved by 
precisely tuning the aqueous phase to the oil phase pressure ratio (Pa/Po). At a cell 
concentration of 2 × 106 per ml, we achieved a maximum encapsulation efficiency of 27 %, 
with a cell doublet rate of 8 % (Fig 2 C). There is a trade-off between the cell doublet rate 
and single cell encapsulation efficiency. If no droplets contain more than one cell (no 
doublets), then the single cell encapsulation efficiency decreases to <10 %. The critical 
parameters that influence the 1–1 efficiency are the droplet diameter, droplet generation 
frequency, cell concentration, and difference in cell-media density.
Oil Phase Characterization for best FLIM performance
In order to ensure the FLIM performance, we determined the optimum oil phase to avoid 
background signal from oil phase, while allowing the rapid and robust acquisition of the 
FLIM signal on cells encapsulated in the droplets. We screened four different oil phase 
solution, Novec 7500 mixed with Dolomite picosurf (mix in the ratio of 4:1), ethyl oleate 
and Ebil EM90, heavy mineral oil with 2% Ebil EM90 and 0.1% Triton X-100 as well as 
oleic acid with 2% Span 80. To quantify the fluorescence intensity and emission spectra 
from the oil phase, we expose the 740nm 2-photon laser to the solutions. The emission 
spectra (Fig. 3) shows that Novec 7500 mixed with Dolomite picosurf (mix in the ratio of 
4:1) and heavy mineral oil with 2% Ebil EM90 and 0.1% Triton X-100 present lowest 
fluorescence intensity which will not interfere with the FLIM imaging collection. Novec 
7500 has been used in pharmaceutical and chemical manufacturing processes since its 
property of cell-friendly and stability which is optimal for live imaging and the down-stream 
PCR test in the future. Therefore, we choose Novec 7500 as our oil phase for the high-
efficiency one-one droplet encapsulation platform.
Differentiation of Leukemia Cell lines in Droplets using FLIM
Two different types of human leukemia cells K562 erythromyeloid and Jurkat T-cell 
leukemia were encapsulated one-to-one in the droplets (Fig. 4). FLIM images were collected 
at 740 nm excitation wavelength. The transmission images of the cells in the device, the 
fluorescence intensity images of the single cells with and without droplet are shown in 
Ma et al. Page 4
Cytometry A. Author manuscript; available in PMC 2020 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4A and 4B. We distinguish the different leukemia cell lines by morphology and 
phasor-FLIM signature (Supplementary Fig. 1, Fig. 4C, D).
Most of the normal leukemia cells have a diameter ranging from 8μm to 20μm, and there 
exist significant size overlap based on our measurement of the leukemia cell lines we 
investigated, K562 and Jurkat cells (Supplementary Fig.1). The diameter of the K562 and 
Jurkat cells are 11.15 μm and 10.48 μm, respectively, which shows no significant difference 
and cannot be distinguished based on morphology. While leukemia cells cannot be 
differentiated by size and shape, the FLIM phasor shows significant difference without any 
label. We applied phasor transformation to the acquired FLIM data and plotted the 
representative scatter plot of phasor-FLIM signature of the leukemia cells in droplets (Fig. 
4C), the Jurkat cells (blue) and K562 cells (red) show a significant difference.
To further quantify the difference of the phasor-FLIM signatures between different cell 
populations and the cellular heterogeneity within the same population, we apply Distance 
analysis to plot the 3D phasor information of individual cells of Jurkat (blue), and K562 
(red) in the bar graph of Fig. 4D(46). Both of K562 erythromyeloid cells and Jurkat T-cell 
leukemia cells demonstrate a relatively shorter lifetime compare to normal cells and 
tissues(34), and as shown, the index shows the cell phasors of the Jurkat cells are 
significantly different from the group of K562 cells. These can be explained by the Warburg 
Effect, in which rapid-proliferating tumor-like cells, i.e., leukemia cells, have stronger 
glycolysis in glucose metabolism to support fast ATP consumption and biosynthesis of 
macromolecules and there is tumor heterogeneity due to different metabolic rate.
Phasor-FLIM measurement of regular and quiescent fibroblast cells in droplets
After identification of the difference in the phasor-FLIM fingerprints of different leukemia 
cell lines (Jurkat and K562), we conducted the rapid label-free single-cell screening to 
understand the quiescent and proliferation metabolic activity and to further observe the rapid 
treatment response. The model we used to monitor the metabolic difference between cellular 
quiescence is human foreskin fibroblast model. Cells from human foreskin fibroblasts cell 
line were treated for 24 hours(Q2) and 72 hours(Q4) with non-serum media, and the phasor-
FLIM signature of each condition was measured(Fig. 5). We collected the NAD(P)H 
fluorescence emission of encapsulated single cells and fluorescence lifetime images at 
740nm excitation and pseudo-colored the higher bound/free-NAD(P)H-ratio group as cyan 
and the higher free/bound-NAD(P)H-ratio group as pink (Fig. 5A, B). The human foreskin 
fibroblasts with different treatment type of serum starvation were clearly distinguished from 
the cells treated using normal condition as highlighted in phasor plot (Fig. 5B) as serum-
starved human foreskin fibroblast cells have more components in the color indicating a 
higher fraction of free NAD(P)H, while normal human foreskin fibroblasts consist of more 
white color pixels indicating a higher fraction of bound NAD(P)H. The fraction of bound 
NAD(P)H/total NAD(P)H shows the quantification of significant increase of the free-form 
of NAD(P)H with serum-free treatment or the induction of cells in a quiescent state. The 72 
hours serum-starvation (Q4) group has a significant shift from high NADPH bound fraction 
to a lower bound fraction (Fig. 5c). This shift, toward a higher free fraction of NADPH and 
shorter lifetime, in the quiescent group (Q4) compared to the proliferating group (P) may be 
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caused by the metabolic shift towards the Warburg effect (increased glycolysis in the 
presence of oxygen) and the pentose phosphate pathway (PPP) pathway (42,47). Under this 
glycolytic state, introduced by serum-starvation, there would be a higher lactate production 
that can create an acidic microenvironment for gene expressions regulation (48–50). This is 
important in tumor progression and wound healing promotion. In addition, the PPP pathway 
can produce more ribose-5-phosphate and NADPH which is needed for the biosynthesis of 
nucleotides and macromolecules including fatty acids. Given that previous reports have 
correlated a link between human newborn fibroblasts and cancer cells in regards to similar 
migratory properties, the screening between cellular state might open a new window of 
further understanding of the basic mechanisms involved in communication between tumor 
cells and fibroblasts as well as cancer dormancy for targeted cancer therapy(51).
Materials and Methods
Microfluidic Device Preparation.
Microfluidic devices were fabricated in polydimethylsiloxane (PDMS, Sylgard 184, Dow 
Corning) using soft lithography(52). The PDMS molded imprints and the plain glass slide is 
plasma treated (Harrick Plasma Inc) for 2 minutes and were brought together to form a 
permanent seal. The device is left in the oven at 120 ° C overnight to regain its natural 
hydrophobicity.
Fluidic setup, Leukemia cell preparation and Imaging.
In the experiments,Novec 7500 mixed with Picosurf surfactant (5 % w/w) (Dolomite) 
constitute the continuous phase, and the cells suspended in the culture media forms the 
dispersed phase. Both the K-562 cells and Jurkat cells (American Type Culture Collection 
(ATCC®)) were cultured in a T-75 cell culture flask using RPMI 1640 as a basal medium to 
which fetal bovine serum (FBS) was added (10% by volume). The cell culture media is 
changed every three days until the cells proliferate to the desired confluency. The cells 
containing medium were then transferred to a 10 mL Eppendorf tube, centrifuged at 1000 
rpm for 5 min and the pellet was re-suspended in the freshly prepared aqueous/dispersed 
phase. The cell concentration in the resulting suspension was determined using an automated 
cell counter (ThermoFisher Scientific) and appropriately diluted to the desired 
concentration.
We used constant pressure source via high-speed solenoid valves controlled by a custom-
built lab view program to automate the fluid injection into the microfluidic chip. The single 
cell encapsulation process was monitored using Nikon 100-S inverted microscope and 
recorded using Phantom camera, V-310 (Vision Research). To analyze the videos frame by 
frame to yield the encapsulation data, we used ImageJ, a public domain java based image 
processing software developed at National Institutes of Health(53).
Fluorescence Lifetime Imaging Microscopy.
Fluorescence lifetime images of the cells encapsulated in high-efficiency microdevice were 
acquired on Zeiss LSM880 (Carl Zeiss, Jena, Germany), a multi-photon microscope coupled 
with a Ti:Sapphire laser (Spectra-Physics Mai Tai, Mountain View, CA) with 80 MHz 
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repetition rate. The FLIM data detection was performed by the photomultiplier tube 
(H7422p-40, Hamamatsu, Japan) and a320 FastFLIM FLIMbox (ISS, Champaign, IL). The 
cells encapsulated in droplets were excited at 740nm. A Zeiss EC Plan-Neofluar 20x/0.8 NA 
objective (Cart Zeiss, Jena, Germany) was used. The following settings were used for the 
measurement: image size of 256×256 pixels, with a scan speed of 16μs/pixel. A dichroic 
filter at 690nm was used to separate the fluorescence signal from the laser light. And the 
emission signal is split with 496nm LP filter and detected in two channels using a bandpass 
filter 460/80 and a 540/50 filter. Only the blue channel (460/80) data was used for this study. 
FLIM calibration of the system was performed by measuring the known lifetime of a 
fluorophore coumarin 6 which has a known fluorescence lifetime of τ=2.5 ns when 
dissolved in ethanol. FLIM data were acquired and processed by the SimFCS software 
developed at the Laboratory of Fluorescence Dynamics (LFD).
Human Foreskin Fibroblast cells preparation.
Human foreskin fibroblast cells were cultured and maintained in a 37°C incubator 
humidified at 5% CO2 atmosphere in Dulbecco’s modified Eagle’s medium/F12(D-MEM) 
(1:1) (11320–033, Life Technologies, Carlsbad, CA), supplemented with 10% fetal bovine 
serum and 1% penicillin streptomycin. The cells were freshly trypsinized and plated onto 35 
mm glass bottom dishes (Mattek Corporation, Ashland, Massachusetts) for imaging. The 
phasor-FLIM signature of NADH bound to lactate dehydrogenase and NADH and NADPH 
(free form) are shown in Supplementary figure 2.
Serum Starvation treatment.
Dulbecco’s modified Eagle’s medium/F12(D-MEM) (1:1) (11320–033, Life Technologies, 
Carlsbad, CA), supplemented with 0.1% fetal bovine serum and 1% penicillin streptomycin 
were prepared for the serum starvation treatment. The Q2 and Q4 cells were serum starved 
for 24 hours and 72 hours respectively.
Statistical analysis.
Data are presented as mean ± standard deviation. For the FLIM data, the statistical analyses 
were performed using student t-test for the g value and the value of the ratio of bound 
NAD(P)H to total NAD(P)H, p<0.05 was considered as statistically significant.
Conclusion
In summary, here we present a non-invasive, label-free single cell analysis platform 
combining the droplet microfluidic technology and the Fluorescence Life Time Imaging 
Microscopy. The single cell encapsulation technique is passive, controlled only by flow rates 
of the two phases and not requiring complex structures or on-chip active devices, and the 
label-free phasor-FLIM characterization is non-invasive without micro-environment 
influence. To identify between encapsulated leukemia cell types (Jurkat and K562 cells) we 
used the phasor-FLIM analysis and showed that excellent bi-classification (AUC: 0.980) in 
calculating the degree of separation between the two cell types. In another example, the 
differences between proliferating versus quiescence states also showed statistically 
significant separation in the phasor-FLIM plots. Given that cells can exhibit a quiescence 
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state where they can exit the cell cycle by reducing their size, DNA syntheses and different 
metabolic activity, it would seem feasible to distinguish them from their metabolic state. 
Indeed our phasor-FLIM analysis showed that the fingerprint of the proliferating versus 
quiescent human fibroblasts under exhibit higher free NADPH under quiescent state versus 
proliferative state. This may be due to the production of citrate from the conversion of α-
ketoglutarate through NADPH shuttling through the mitochondria. In quiescence, NADPH is 
generated as a means to utilize this co-factor to synthesize fatty acids. This would indicate a 
higher production of NADPH would be produced to detoxify free radicals or to synthesize 
fatty acids under a quiescent state. The phasor analysis proved to be effective in identifying 
between a proliferative versus a quiescent state that can be coupled to our single cell 
encapsulation design(42). The future directions of this project would be to further improve 
and optimize the parameters to maximize the encapsulation efficiency, perform large-scale 
FLIM characterization, and to incorporate the genotyping unit downstream to correlate with 
the phenotypic signature. Our finding suggests that FLIM-single oil droplet technique is 
promising as it expands the capabilities of droplet microfluidics to address applications 
related to single-cell high throughput early stage tumor and leukemia screening and 
personalized therapy by targeting quiescent tumor cells.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1: 
Single cell encapsulation in droplets: (A) Device schematic: Cells introduced from the left 
inlet are encapsulated 1–1 into the droplets which is dictated by the Poisson statistics (B) 
Microfluidic device made of PDMS, which is used for single cell encapsulation as well as 
FLIM characterization. Inset shows the droplets if collected in the uniquely designed 
collection chamber. It prevents the droplet motion during FLIM measurements to a 
considerable extent.
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Figure 2: 
(A) Demonstration of the single cell encapsulation process. The red circle indicates the 
presence of one cell. (B) Droplets collected after the encapsulation process. The presence of 
cells is highlighted in red. (C) Graphic illustrating the encapsulation efficiency of k-562 cells 
in droplets. Efficiency increases with the droplet diameter and peaks at an optimum 
diameter. However, it is observed that the efficiency decreases beyond a threshold diameter 
due to multiple encapsulations (doublets/triplets) (not shown).
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Figure 3. 
Oil Phase Emission Spectra test(740nm excitation) for Oil 1(red)- Novec 7500 mixed with 
Dolomite picosurf (mix in the ratio of 4:1), Oil 2(blue)- ethyl oleate and Ebil EM90, Oil 
3(green)- heavy mineral oil with 2% Ebil EM90 and 0.1% Triton X-100, Oil 4(cyan)- oleic 
acid with 2% Span 80.
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Figure 4. 
A) Transmission images, fluorescence intensity images of the K562 and Jurkat cells 
respectively within droplets and without droplets. Scale bar: 100 μm. B) Scatter plot shows 
the zoomed in phasor-FLIM results of the single leukemia cells in the high efficiency 
encapsulated droplets for both K562 (red) and Jurkat (blue) cells. The different leukemia cell 
lines K562 and Jurkat have significant difference, with a p-value for g, 0.025 and s, 0.0002. 
C) Bar graph of classification index of leukemia cell lines. K562 cells are shown in red, 
Jurkat cells are in blue. The area under curve (AUC) is 0.980. (K562 group, n=33, Jurkat 
group, n=32).
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Figure 5. 
A) Fluorescence intensity images of the single cell within droplets, and FLIM images of the 
human foreskin fibroblast under regular proliferation condition(P), serum starved for 2 
days(Q2), and serum starved for 4 days(Q4). The FLIM images were pseudocolored by the 
color bar in Fig. 5B, scale bar: 50 μm. B) Phasor plot shows the FLIM signature distribution 
of the P, Q2 and Q4 conditions. From Cyan to Pink, the color shows the signature move 
from the long lifetime (higher Bound/Free NAD(P)H) to the short lifetime (lower Bound/
Free NAD(P)H). C) Bar graph shows the bound NAD(P)H/Total NAD(P)H ratio of the P, Q2 
and Q4 conditions. The Q2 and Q4 group shows significant decreasing of Bound NAD(P)H, 
p-value for P and Q2 groups is 0.001, p-value for P and Q4 group is 0.002 (P group, n=21, 
Q2 group, n=4, Q4 group, n=19).
Ma et al. Page 16
Cytometry A. Author manuscript; available in PMC 2020 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
